البريد الإلكتروني: bd@sidmexinovia.com
رقم الهاتف: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
الرئيسية >
Pegihep 80mcg Injection
Pegihep 80mcg Injection
Manufacturer/Marketed By : ZYDUS CADILA
$75.44 $60.36
Pegihep 80mcg injection is an antineoplastic drug that belongs to the category of medicines known as interferons, containing the active ingredient Pegylated Interferon Alpha-2B. It is used to treat chronic...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
PEGYLATED INTERFERON ALPHA-2B
Active Pharmaceutical Ingredient
Pegihep 80mcg Injection
75.44 US$
60.36 US$
Pegihep 80mcg injection is an antineoplastic drug that belongs to the category of medicines known as interferons, containing the active ingredient Pegylated Interferon Alpha-2B. It is used to treat chronic hepatitis C infection in patients above 18 years of age with compensated liver disease. Hepatitis C infection is a viral infection that affects the liver. This infection can spread through contact with infected blood, by sharing needles or other drug injection equipment, or less commonly through sexual contact, sharing personal hygiene items, or from mother to baby during childbirth. This medicine should be used with caution in patients with creatinine clearance below 50 mL/min, as this indicates moderate to severe impairment of renal function. This can lead to slower clearance of the medication, which may increase the risk of toxicity and adverse effects. The dosage of this drug should be reduced in these patients, and they should be closely monitored for signs of toxicity, such as fatigue, depression, or decreased white blood cell count. Therefore, the dose should be adjusted accordingly in patients with renal impairment. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. As this drug may cause harm to an unborn baby, it is advised for both men and women to follow proper contraceptive methods during and one week after the last dose of Pegihep 80mcg injection. Avoid breastfeeding your baby while you are on the treatment, as this drug can impact the growth and development of the baby by passing into the breast milk. It is not recommended to take this injection if you are allergic to the drug or any of its ingredients. If you experience any signs of an allergic reaction, such as hives, difficulty breathing, or swelling of the face or throat, report to your doctor immediately. This drug is contraindicated in patients with decompensated liver disease. It is a serious condition where the liver is severely damaged and is no longer able to function properly, so it is highly advised to avoid taking this medicine.
Active Pharmaceutical Ingredient
الاستخدامات
• Chronic Hepatitis C (CHC)
فوائد
Pegihep 80mcg injection works by stimulating the body's immune system to fight off viral infections and cancer cells. Specifically, it activates certain immune cells, such as natural killer cells and T-cells, to attack and eliminate the infected virus or cancerous cells.
تأثيرات جانبية
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
الآثار الجانبية الأكثر شيوعًا
• Tiredness
• Flu-like symptoms
• Headache
• Loss of appetite
• Hair loss
• Muscle pain
• Anxiety
• Anaemia
• Irritability
• Insomnia
• Fainting
• Eye irritation and disturbance
• Injection site reactions
• Weight loss
الآثار الجانبية الشائعة
• Low or high BP
• Increased heart rate
• Depression
كيفية الاستخدام
Pegihep 80mcg injection injection is administered as a subcutaneous injection (under your skin). If this drug is recommended for you, it will be given by a doctor. Do not self-administer. the recommended dose is 1.5 micrograms/kg/week. Your doctor will choose the dosage and administration frequency based on the condition because it differs from person to person.
نصائح السلامة
• Breast Feeding: It is unsafe to breastfeed during the treatment with Pegihep 80mcg injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.
• Alcohol: Consuming alcohol may affect the effectiveness of the Pegihep 80mcg injection. Stop consuming alcohol if you are taking this medicine.
• Liver: Inform your doctor if you have any liver problems before taking Pegihep 80mcg injection. Regular monitoring of liver function tests is recommended.
• Lungs: It is not known whether Pegihep 80mcg injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Pegihep 80mcg injection, it may cause dizziness and impair your concentration.
• Pregnancy: Pegihep 80mcg injection is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
تنصل
تسعى شركة Sidmex Inovia جاهدة لتوفير معلومات دقيقة وموثوقة؛ ومع ذلك، فإن جميع المحتويات الموجودة على هذا الموقع الإلكتروني، بما في ذلك أوصاف المنتجات ومكوناتها، هي لأغراض إعلامية فقط ولا ينبغي اعتبارها بديلاً عن المشورة الطبية المهنية أو التشخيص أو العلاج.
يُنصح المستخدمون باستشارة أخصائي رعاية صحية مؤهل قبل اتخاذ أي قرارات طبية. لا ينبغي استخدام المعلومات المقدمة للتشخيص الذاتي أو العلاج الذاتي.
جميع المنتجات المذكورة مخصصة حصراً لأغراض التعاملات التجارية بين الشركات والاستفسارات بالجملة. لا تشجع شركة سيدمكس إينوفيا الاستخدام المباشر من قبل المستهلكين، وتهدف إلى دعم العلاقة بين أخصائي الرعاية الصحية والمريض، لا استبدالها.
جميع أسماء المنتجات والعلامات التجارية والأسماء التجارية مملوكة لأصحابها، ولا يعني استخدامها أي انتماء أو تأييد. لا تتحمل شركة سيدمكس إينوفيا أي مسؤولية عن أي تبعات ناتجة عن استخدام المعلومات الواردة في هذا الموقع الإلكتروني.



